Study of Cediranib Plus Cisplatin Plus Capecitabine/S-1 in Japanese Gastric Cancer Patients

NCT00960349 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Cediranib
DRUG: Cisplatin
DRUG: S-1
DRUG: Cisplatin
DRUG: Capecitabine

Sponsor

AstraZeneca